Miragen Therapeutics Inc (NASDAQ:MGEN)

6.62
Delayed Data
As of Apr 25
 +0.20 / +3.12%
Today’s Change
5.01
Today|||52-Week Range
15.91
-36.53%
Year-to-Date
No recent news for Miragen Therapeutics Inc.

Today’s Trading

Previous close6.42
Today’s open6.46
Day’s range6.35 - 6.73
Volume82,173
Average volume (3 months)294,512
Market cap$155.9M
Data as of 4:00pm ET, 04/25/2018

Growth & Valuation

Earnings growth (last year)+16.34%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.59%
Revenue growth (last year)+31.48%
P/E ratioNM
Price/Sales1.08
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MNOVMediciNova Inc+0.98+9.32%
CRHMCRH Medical Corp0.000.00%
NYMXNymox Pharmaceutical...-0.04-0.94%
MACKMerrimack Pharmaceut...-0.13-1.54%
Data as of 4:00pm ET, 04/25/2018

Financials

Next reporting dateMay 9, 2018
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$3.3M
Annual profit (last year)-$12.7M
Net profit margin-379.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
William S. Marshall
Chief Financial Officer, Secretary &
Treasurer
Jason A. Leverone
Corporate headquarters
Boulder, Colorado

Forecasts